Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension.

Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW.

Chest. 2001 Nov;120(5):1639-44.

PMID:
11713147
2.

Lipid mediator dysregulation in primary pulmonary hypertension.

Christman BW.

Chest. 1998 Sep;114(3 Suppl):205S-207S. Review.

PMID:
9741570
3.

On the role of PGD2 metabolites as markers of mast cell activation in asthma.

O'Sullivan S.

Acta Physiol Scand Suppl. 1999 Apr;644:1-74. Review.

PMID:
10352758
4.

Prostacyclin among prostanoids.

Gryglewski RJ.

Pharmacol Rep. 2008 Jan-Feb;60(1):3-11. Review.

5.

Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites.

Higashi N, Taniguchi M, Mita H, Yamaguchi H, Ono E, Akiyama K.

Allergol Int. 2012 Sep;61(3):393-403. doi: 10.2332/allergolint.11-RA-0403. Epub 2012 May 25. Review.

6.

Thromboxane receptors antagonists and/or synthase inhibitors.

Davì G, Santilli F, Vazzana N.

Handb Exp Pharmacol. 2012;(210):261-86. doi: 10.1007/978-3-642-29423-5_11. Review.

PMID:
22918735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk